These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7567012)
1. Positron emission tomography in the detection of residual laryngeal carcinoma. Austin JR; Wong FC; Kim EE Otolaryngol Head Neck Surg; 1995 Oct; 113(4):404-7. PubMed ID: 7567012 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of Kim SY; Crook D; Rosskopf J; Lee JH Head Neck; 2024 Sep; 46(9):2284-2291. PubMed ID: 38712471 [TBL] [Abstract][Full Text] [Related]
3. Therapy evaluation of laryngeal carcinomas by tyrosine-pet. De Boer JR; Pruim J; Burlage F; Krikke A; Tiebosch AT; Albers FW; Vaalburg W; Van Der Laan BF Head Neck; 2003 Aug; 25(8):634-44. PubMed ID: 12884346 [TBL] [Abstract][Full Text] [Related]
4. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic management of head and neck malignancies with positron emission tomography. Reisser C; Haberkorn U; Dimitrakopoulou-Strauss A; Seifert E; Strauss LG Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):272-6. PubMed ID: 7873142 [TBL] [Abstract][Full Text] [Related]
6. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy]. Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113 [TBL] [Abstract][Full Text] [Related]
7. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma]. Haenggeli CA; Dulguerov P; Slosman D; Becker M; Bang P; Allal A; Guyot JP; Lehmann W Schweiz Med Wochenschr Suppl; 2000; 116():8S-11S. PubMed ID: 10780061 [TBL] [Abstract][Full Text] [Related]
8. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032 [TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422 [TBL] [Abstract][Full Text] [Related]
10. Clinical Utility of Pretreatment and 3-Month Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209 [TBL] [Abstract][Full Text] [Related]
11. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292 [TBL] [Abstract][Full Text] [Related]
12. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825 [TBL] [Abstract][Full Text] [Related]
13. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795 [TBL] [Abstract][Full Text] [Related]
14. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451 [TBL] [Abstract][Full Text] [Related]
15. Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography. Horiuchi C; Taguchi T; Yoshida T; Nishimura G; Kawakami M; Tanigaki Y; Matsuda H; Mikami Y; Oka T; Inoue T; Tsukuda M Auris Nasus Larynx; 2008 Mar; 35(1):103-8. PubMed ID: 17825512 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460 [TBL] [Abstract][Full Text] [Related]
17. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276 [TBL] [Abstract][Full Text] [Related]
18. PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy. Sistonen HJ; Ilmarinen T; Atula T; Aro K; Schildt J; Markkola A BMC Cancer; 2023 Apr; 23(1):358. PubMed ID: 37072716 [TBL] [Abstract][Full Text] [Related]
19. Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach. Rousset J; Abgral R; Chinellato S; Garetier M; Barberot C; Valette G; Potard G; Le Bivic T; Salaun PY Head Neck; 2013 Jul; 35(7):E202-4. PubMed ID: 22619005 [TBL] [Abstract][Full Text] [Related]
20. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Case LD Cancer J Sci Am; 1997; 3(6):353-7. PubMed ID: 9403048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]